These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25319490)

  • 21. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma.
    Bujía J; Kim C; Boyle D; Hammer C; Firestein G; Kastenbauer E
    Laryngoscope; 1996 Feb; 106(2 Pt 1):217-20. PubMed ID: 8583857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A study on expression of tumor necrosis factor alpha in middle ear cholesteatoma and its effect on bone destruction].
    Li Z; Li X; Liu G
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):66-7. PubMed ID: 12541866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
    Shinoda H; Huang CC
    Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of long non-coding RNA HOTAIR expression in middle ear cholesteatoma].
    Li Q; Wang HQ; Chen YQ; Xiong S; Zeng L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(4):250-253. PubMed ID: 29871236
    [No Abstract]   [Full Text] [Related]  

  • 25. Partial Epithelial-Mesenchymal Transition Was Observed Under p63 Expression in Acquired Middle Ear Cholesteatoma and Congenital Cholesteatoma.
    Takahashi M; Yamamoto-Fukuda T; Akiyama N; Motegi M; Yamamoto K; Tanaka Y; Yamamoto Y; Kojima H
    Otol Neurotol; 2019 Sep; 40(8):e803-e811. PubMed ID: 31348131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cathepsin L activity and its inhibitor in human otitis media.
    Kusunoki T; Nishida S; Murata K; Kobashi K; Nakatani H; Hiwasa T; Tomura T
    J Otolaryngol; 2001 Jun; 30(3):157-61. PubMed ID: 11771045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The expression of Ras protein in human middle ear cholesteatoma].
    Xu Y; Jin K; Dong W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of secretory leukocyte protease inhibitor in middle ear cholesteatoma.
    Lee JK; Chae SW; Cho JG; Lee HM; Hwang SJ; Jung HH
    Eur Arch Otorhinolaryngol; 2006 Dec; 263(12):1077-81. PubMed ID: 16868773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell cycle inhibitory protein p27 in human middle ear cholesteatoma.
    Kuczkowski J; Bakowska A; Pawelczyk T; Narozny W; Mikaszewski B
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(5):296-301. PubMed ID: 16825801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium.
    Kojima H; Miyazaki H; Tanaka Y; Shiwa M; Koga T; Moriyama H
    Arch Otolaryngol Head Neck Surg; 1999 Jul; 125(7):738-42. PubMed ID: 10406309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Is reuse of autologous ear ossicles in cholesteatoma or chronic suppurative otitis media justified?].
    Peng JC; Hoppe F
    Laryngorhinootologie; 1994 Jul; 73(7):375-80. PubMed ID: 7916783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential gene expression in cholesteatoma by DNA chip analysis.
    Macias JD; Gerkin RD; Locke D; Macias MP
    Laryngoscope; 2013 Oct; 123 Suppl S5():S1-21. PubMed ID: 23670528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between human beta defensin expression and cholesteatoma formation.
    Meyer JE; Schwaab M; Beier UH; Görögh T; Buchelt T; Frese K; Maune S
    Auris Nasus Larynx; 2006 Jun; 33(2):159-65. PubMed ID: 16431059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Micronucleus frequency in acquired middle ear cholesteatoma.
    Oztürk K; Yildirim MS; Acar H; Arikoğlu H; Arbağ H; Ozer B
    Acta Otolaryngol; 2004 Oct; 124(8):924-8. PubMed ID: 15513528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
    Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
    Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hexosoaminidase gene expression in cholesteatoma in adults].
    Rutkowska J; Olszewska E; Waniewska E; Czechowska S; Kowalczuk O; Borawska M; Zukowska M; Markiewicz R; Rogowski M
    Otolaryngol Pol; 2009; 63(6):490-5. PubMed ID: 20198983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The roles of interleukin-1 alpha, tumor necrosis factor-alpha and parathyroid hormone-related protein in bone resorption of cholesteatoma otitis].
    Kinoshita K
    Nihon Jibiinkoka Gakkai Kaiho; 1994 Aug; 97(8):1472-80. PubMed ID: 7931803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma.
    Kojima H; Shiwa M; Kamide Y; Moriyama H
    Acta Otolaryngol; 1994 Jul; 114(4):423-9. PubMed ID: 7976315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of metallothionein 2 in middle ear cholesteatoma and its correlation with interleukin 1α and interleukin 6].
    Liu Y; Yu LL; Han J; Cheng JN; Yang DZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 47(10):831-5. PubMed ID: 23302165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of placenta growth factor in human middle ear cholesteatoma.
    Cho JG; Lim HW; Woo JS; Hwang SJ; Lee HM; Chae SW
    Acta Otolaryngol; 2006 Sep; 126(9):900-4. PubMed ID: 16864484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.